ABVC BioPharma, Inc.
ABVC BioPharma, Inc. (ABVC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ABVC · as of Jun 9, 2026
Key Statistics
Explore ABVC BioPharma, Inc. Data
abvc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
abvc competitorsABVC
ATNM
FGEN
GRCE
JUNS
LTRNStock Performance
Full HistoryAbout ABVC BioPharma, Inc.
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States…
what is abvc biopharma, inc. · abvc stock overview · abvc biopharma, inc. company profile · who is abvc biopharma, inc. ceo · abvc NASDAQ · abvc biopharma, inc. headquarters · abvc biopharma, inc. business segments
About Stock Overview & Key Data
ABVC BioPharma, Inc. (ABVC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 10, 2004. As of the latest trading session, ABVC stock price is $1.37, with a market capitalization of $19.5M. The stock has returned -17.04% over the past 12 months and -36.91% year-to-date.
According to 1 Wall Street analysts, the consensus rating for ABVC BioPharma, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, ABVC BioPharma, Inc. reported revenue of — and net income of -$7.9M. For detailed data — including ABVC BioPharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, ABVC BioPharma, Inc. (ABVC) stock price is $1.37. The stock is traded on NASDAQ under the ticker symbol ABVC. The 52-week range is $0.88 – $5.48.